Selected Publications

P. R. Fatouros, U. Roy, S. Sur, Implications of SARS-CoV-2 Spike Protein Interactions with Zn-bound form of ACE2: A Computational Structural Study, BioMetals 36, 903-912 (2023). doi: https://doi.org/10.1007/s10534-023-00491-z. This article has been included in "PubMed Central COVID-19 Collection" by Springer Nature.

P. R. Fatouros, U. Roy, S. Sur, Modeling Substrate Coordination to Zn-Bound Angiotensin Converting Enzyme 2, International Journal of Peptide Research and Therapeutics 28: 2 (2022). https://link.springer.com/article/10.1007/s10989-022-10373-6

U. Roy and L. A. Luck, Cysteine residues in heavy metal binding proteins: structural insights and comparison with leucine binding protein, Journal of Chemistry and Chemical Engineering 5, 771-777 (2011).

M.C. Debnath, U. Roy, K.K. Halder, B.R. Sarkar, S. Sinha and S. Ganguly, Technetium-99m cysteine; A novel radiopharmaceutical for detection of experimental myocardial infarction in rats, Current Radiopharmaceuticals 3, 290-296 (2010). DOI: 10.2174/1874471011003040290.

U. Roy, M. Chatterjee Debnath, K. Sanyal, M. K. Das, S. Banerjee , Role of protecting groups in the preparation of thiolate complexes of technetium -99m using cysteine as a model, Journal of Labelled Compounds and Radiopharmaceuticals 49, 10, 835-847 (2006). https://doi.org/10.1002/jlcr.1084.

 

Recent Presentations

P. Fatouros*, U. Roy, S. Sur, Modeling the SARS-CoV-2 Receptor ACE2 Indicates that Protein-Bound Zn Affects Distant Protein Stability and Interactions, The Journal of Immunology (The American Association of Immunologists) 210, Issue 1_Supplement (2023) https://doi.org/10.4049/jimmunol.210.Supp.249.23.
   Presented by P. Fatouros*at IMMUNOLOGY2023 conference, Washington DC. (* Honors student co-advised with Dr. S. Sur)

P. Fatouros, S. Sur, U. Roy, Modeling Inhibitor Coordination to Zn-Bound Angiotensin Converting Enzyme 2, Talk presented by P. Fatouros* at eRAPS, Summer 2020, Clarkson University, NY.

Back to Previous Page